|
|||||
|
|
Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma |
|
| Authors: | E. Herrmann N. Marschner M. O. Grimm C. H. Ohlmann U. Hutzschenreuter F. Overkamp M. Groschek K. Blumenstengel G. Pühse T. Steiner |
| Affiliation: | 1. Department of Urology, University of Münster, Albert-Schweitzer Strasse 33, 48149, Münster, Germany 2. Medical Practice for Oncology and Hematology, Freiburg, Germany 3. Department of Urology, University of Dresden, Dresden, Germany 4. Department of Urology, University of the Saarland, Homburg, Germany 5. Medical Practice for Oncology and Hematology, Nordhorn, Germany 6. Medical Practice for Oncology and Hematology, Recklinghausen, Germany 7. Medical Practice for Oncology and Hematology, Würselen, Germany 8. Medical Practice for Oncology and Hematology, Eisenach, Germany 9. Department of Urology, University Hospital Jena, Jena, Germany |
| Abstract: | PurposeTo investigate whether patients with metastatic renal cell carcinoma benefit from sequential therapies with the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib. |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |